Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael W. Cho
Iowa State University, Department: Veterinary Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeoVaxSyn Incorporated
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Development of a vaccine strategy using antibody-complexed antigens
AIDS pandemic during the past three decades has killed an estimated 39 million people. In 2013, there were an estimated 1.5 million deaths, 2.1 million new infections, and 35 million people infected with HIVC1. A protective vaccine is the only economically feasible solution to end the pandemic. Abs that can neutralize (or block) HIVC1 infections are important components of the body's immune system. The critical roadblock to AIDS vaccine development is the difficulty in eliciting neutralizing Abs that are broadly reactive against many different variants of the virus that exist. The major goal of this proposal is to explore a novel vaccine strategy that could possibly induce broadly neutralizing Abs. Thus, successful completion of the proposed studies will overcome a critical roadblock to AIDS vaccine development.
Filed on March 14, 2016.
Tell us what you know about Michael W. Cho's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael W. Cho filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Cho | Iowa State University | Conflict of Interest | NeoVaxSyn Incorporated | Value cannot be readily determined |
| Michael Cho | Iowa State University | Conflict of Interest | NeoVaxSyn Incorporated | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.